ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

Hong Succeeds Curran As AACR President, Horwitz Is President-Elect; 5 New Directors.

March 30, 2001

Higher Tobacco Tax Will Save Lives, Groups Tell Clinton, congress

January 22, 1993

Obituaries: Fritz Bach, 77, and William Wolff, 94

September 9, 2011

Officials: Poisoning Unrelated to MD Anderson; Critics Allege Dysfunction in Handling of Affair

September 19, 2014

Smoking & Health Contractors Meet

July 11, 1975

Roswell Park Researchers Advocate HPV Vaccination For Boys As Well As Girls

May 29, 2009